Therapeutic viral vaccine
Showing 1 - 25 of >10,000
HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1
Not yet recruiting
- HIV Vaccine
- Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
- +2 more
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023
Solid Tumor, Adult Trial in Beijing (Vaccine)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 3, 2023
COVID-19, Therapeutic Vaccine, BCG Trial in Campinas (BCG, Placebo)
Active, not recruiting
- COVID-19
- +4 more
- BCG
- Placebo
-
Campinas, SP, BrazilHospital das Clínicas Unicamp
Mar 23, 2022
HSIL of Cervix Trial in Heze (NWRD08)
Recruiting
- HSIL of Cervix
- NWRD08
-
Heze, Shandong, ChinaHeze Municipal Hospital
Jun 6, 2023
COVID-19, SARS-CoV-2 Infection Trial in Morelia (Recombinant COVID-19 variant Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- Recombinant COVID-19 variant Vaccine (Sf9 Cell)
- +3 more
-
Morelia, Michoacán De Ocampo, MexicoClínica de Enfermedades Crónicas y de Procedimientos Especiales,
Jul 18, 2022
Hepatitis B, Chronic Trial in Worldwide (ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation,
Recruiting
- Hepatitis B, Chronic
- ChAd155-hIi-HBV low dose formulation
- +6 more
-
Antwerpen, Belgium
- +35 more
Jan 28, 2022
Chronic Hepatitis b Trial in Adelaide (Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine)
Not yet recruiting
- Chronic Hepatitis b
- Therapeutic hepatitis B vaccine
- Commercial Hepatitis B vaccine
-
Adelaide, South Australia, AustraliaFlinders University
Mar 7, 2022
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
Squamous Cell Carcinoma of Head and Neck Trial (0.5 mL Candin®/injection, Placebo: 0.5 mL Intravenous 0.9% NaCl solution
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- 0.5 mL Candin®/injection
- Placebo: 0.5 mL Intravenous 0.9% NaCl solution (Saline)
- (no location specified)
Jul 17, 2023
Viral Wart Trial in ABbottabad (COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR
Completed
- Viral Wart
- COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
-
ABbottabad, KPK, PakistanAdeel Siddiqui
Feb 21, 2023
Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)
Not yet recruiting
- Advanced Ovarian Cancer
- AST-201
- +4 more
-
Seattle, WashingtonUniversity of Washington
Mar 20, 2023
Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)
Not yet recruiting
- Chronic Hepatitis B
- HEPLISAV B; TherVacB
- TherVacB
-
Hamburg, GermanyCTC North
Feb 3, 2023
Tumor Vaccines for Solid Tumors
Recruiting
- Glioma
- Solid Tumor
- tumor vaccine
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital, Fudan University
Oct 22, 2023
Prevent Hospitalizations for Viral Respiratory Infections in
Not yet recruiting
- Severe Acute Respiratory Infection (SARI)
- +2 more
-
Dijon, France
- +7 more
Oct 17, 2022
Infectious Disease, Yellow Fever, Japanese Encephalitis Trial (Stamaril, Imojev, Ixiaro)
Not yet recruiting
- Infectious Disease
- +3 more
- Stamaril
- +2 more
- (no location specified)
Oct 3, 2022
CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic
Recruiting
- CIN3
- +3 more
- Vvax001 therapeutic cancer vaccine
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
COVID-19, SARS-CoV-2 Infection Trial in Iloilo City (Recombinant COVID-19 Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),
Recruiting
- COVID-19
- SARS-CoV-2 Infection
- Recombinant COVID-19 Vaccine (Sf9 Cell)
- COVID-19 Vaccine (Vero Cell), Inactivated
-
Iloilo City, PhilippinesIloilo Doctors Hospital
Jul 18, 2022
Viral Vaccines Trial in Philadelphia (Inactivated influenza vaccine)
Active, not recruiting
- Viral Vaccines
- Inactivated influenza vaccine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 22, 2022
Viral Respiratory Tract Infection, Influenza Trial in Montréal (Administration of FluMist (Live Attenuated Influenza Vaccine))
Active, not recruiting
- Viral Respiratory Tract Infection
- Influenza
- Administration of FluMist (Live Attenuated Influenza Vaccine)
-
Montréal, Quebec, CanadaCentre for Innovative Medicine - McGill University Health Centre
Jul 29, 2022
Host Genetic Factors Underlying Ebola Virus Disease Risk,
Completed
- Ebola Virus Disease
-
Kalkata, Liberia
- +3 more
Aug 18, 2022
Verruca Viral Trial in Zagazig (Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine, Bivalent Human
Completed
- Verruca Viral
- Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
- +2 more
-
Zagazig, Select Region, EgyptDermatology department, Zagazig University Hospitals, Faculty of
May 17, 2022
Eight Years After Vaccination of Children 12 to 23 Months With
Not yet recruiting
- Measles Vaccine
- (no location specified)
Dec 9, 2021
Malaria Trial (Pyronaridine Tetraphosphate, Artesunate Drug Combination, PfSPZ Challenge (NF54), MVA ME-TRAP)
Not yet recruiting
- Malaria
- Pyronaridine Tetraphosphate, Artesunate Drug Combination
- +4 more
- (no location specified)
Jun 27, 2022